» Articles » PMID: 37993709

Epithelial IFNγ Signalling and Compartmentalized Antigen Presentation Orchestrate Gut Immunity

Overview
Journal Nature
Specialty Science
Date 2023 Nov 22
PMID 37993709
Authors
Affiliations
Soon will be listed here.
Abstract

All nucleated cells express major histocompatibility complex I and interferon-γ (IFNγ) receptor, but an epithelial cell-specific function of IFNγ signalling or antigen presentation by means of major histocompatibility complex I has not been explored. We show here that on sensing IFNγ, colonic epithelial cells productively present pathogen and self-derived antigens to cognate intra-epithelial T cells, which are critically located at the epithelial barrier. Antigen presentation by the epithelial cells confers extracellular ATPase expression in cognate intra-epithelial T cells, which limits the accumulation of extracellular adenosine triphosphate and consequent activation of the NLRP3 inflammasome in tissue macrophages. By contrast, antigen presentation by the tissue macrophages alongside inflammasome-associated interleukin-1α and interleukin-1β production promotes a pathogenic transformation of CD4 T cells into granulocyte-macrophage colony-stimulating-factor (GM-CSF)-producing T cells in vivo, which promotes colitis and colorectal cancer. Taken together, our study unravels critical checkpoints requiring IFNγ sensing and antigen presentation by epithelial cells that control the development of pathogenic CD4 T cell responses in vivo.

Citing Articles

Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection.

Cremin M, Ramirez V, Sanchez K, Tay E, Murray K, Brust-Mascher I Proc Natl Acad Sci U S A. 2025; 122(7):e2415287122.

PMID: 39937862 PMC: 11848390. DOI: 10.1073/pnas.2415287122.


The renaissance of oral tolerance: merging tradition and new insights.

Cerovic V, Pabst O, Mowat A Nat Rev Immunol. 2024; 25(1):42-56.

PMID: 39242920 DOI: 10.1038/s41577-024-01077-7.


Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection.

Cremin M, Ramirez V, Sanchez K, Tay E, Murray K, Brust-Mascher I bioRxiv. 2024; .

PMID: 38979288 PMC: 11230291. DOI: 10.1101/2024.06.24.599421.


Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling.

Muzes G, Sipos F Int J Mol Sci. 2024; 25(11).

PMID: 38892354 PMC: 11173330. DOI: 10.3390/ijms25116167.


Current applications of intestinal organoids: a review.

Xiang T, Wang J, Li H Stem Cell Res Ther. 2024; 15(1):155.

PMID: 38816841 PMC: 11140936. DOI: 10.1186/s13287-024-03768-3.


References
1.
Ivashkiv L . IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018; 18(9):545-558. PMC: 6340644. DOI: 10.1038/s41577-018-0029-z. View

2.
Dahlhamer J, Zammitti E, Ward B, Wheaton A, Croft J . Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016; 65(42):1166-1169. DOI: 10.15585/mmwr.mm6542a3. View

3.
Kappelman M, Moore K, Allen J, Cook S . Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2012; 58(2):519-25. PMC: 3576554. DOI: 10.1007/s10620-012-2371-5. View

4.
Ran Kim E, Kyung Chang D . Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014; 20(29):9872-81. PMC: 4123369. DOI: 10.3748/wjg.v20.i29.9872. View

5.
Podolsky D, Isselbacher K . Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology. 1984; 87(5):991-8. View